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Abstract
Introduction: Since 2008, the Singapore Ministry of Health (MOH) has expanded HIV testing by increasing anonymous HIV
test sites, as well as issuing a directive to hospitals to offer routine voluntary opt out inpatient HIV testing. We reviewed this
program implemented at the end of 2008 at Tan Tock Seng Hospital (TTSH), the second largest acute care general hospital
in Singapore.
Methods and Findings: From January 2009 to December 2010, all inpatients aged greater or equal than 21 years were
screened for HIV unless they declined or were not eligible for screening. We reviewed the implementation of the Opt Out
testing policy. There were a total of 93,211 admissions; 41,543 patients were included based on HIV screening program
eligibility criteria. Among those included, 79% (n=32,675) opted out of HIV screening. The overall acceptance rate was 21%.
Majority of eligible patients who were tested (63%) were men. The mean age of tested patients was 52 years. The opt out
rate was significantly higher among females (OR: 1.5, 95%CI: 1.4–1.6), aged .60 years (OR: 2.3, 95%CI: 2.2–2.4) and Chinese
ethnicity (OR: 1.7, 95%CI:1.6–1.8). The false positive rate of the HIV screening test is 0.56%. The proportion of patients with
HIV infection among those who underwent HIV screening is 0.18%. All16 confirmed HIV patients were linked to care.
Conclusion: The default opt-in rate of inpatient HIV testing was low at Tan Tock Seng Hospital, Singapore. Efforts to address
individual HIV risk perception and campaigns against HIV stigma are needed to encourage more individuals to be tested for
HIV.
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Introduction
In 2010, the Singapore Ministry of Health (MOH) reported 441
new diagnoses of HIV infection, resulting in a cumulative total of
4,845 patients with HIV/AIDS in the country. More than half of
patients newly diagnosed with HIV infection are in the advanced
stage of the disease [1]. Prevalence rates of HIV infection range
from 0.1% [1] to an estimated 0.3% [2]. From 2008 to the
present, the MOH has expanded HIV testing by increasing the
number of anonymous HIV test sites, making rapid HIV tests
available, as well as issuing a directive to hospitals to offer routine
voluntary screening with opt out inpatient HIV testing.
These recommendations followed more recent United States
Centers for Disease Control guidelines on HIV screening [3], and
the results of an unlinked, anonymous HIV seroprevalence survey
conducted by the Singapore MOH in 2007 in 5 public hospitals
which reported the prevalence of undiagnosed HIV infection at
0.28% [4]. These efforts to make HIV testing routine in medical
settings have begun to achieve the dual public health goals of
increasing the proportion of individuals aware of their status and
providing these patients with access to HIV care and treatment as
well as constituting an important prevention tool to slow the
spread of HIV.
Tan Tock Seng Hospital (TTSH) is Singapore’s second largest
acute care general hospital, with 1,481 beds in a geographically
central location within Singapore. Here we report the results of a
voluntary inpatient opt out HIV testing program at TTSH, in
compliance with the MOH directive for routine opt out HIV
testing.
Methods
From January 2009 to December 2010, designated HIV
counselors from TTSH offered bedside educational information
and HIV screening to inpatients admitted at TTSH if the medical
team deemed the patient eligible for HIV screening. All inpatients
aged 21 years and above were screened for HIV unless they
decline or are not eligible for screening. Patients were not
approached about HIV screening if they had dementia, delirium,
were admitted to the intensive care unit or high dependency unit,
had a do-not-resuscitate (DNR) order, had known HIV, or had
had an HIV test within the previous 6 months.
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an HIV antibody test using Electrochemiluminescence Immuno-
assay or ECLIA (Elecsys HIV Combi Test, Roche Diagnostics)
done in the Department of Laboratory Medicine. This test is an
immunoassay for the in vitro determination of HIV-1 p 24 antigen
and antibodies to HIV-1, including group O, and HIV-2 in
human serum and plasma. Any patient with a reactive HIV
antibody test received a Western blot confirmation at the National
HIV Reference Laboratory. It is mandatory in Singapore to send
these samples to this laboratory for confirmation of HIV.
The combined cost of the HIV antibody and Western Blot test
was between S$6.00 to S$10.00. Costs varied depending on level
of government subsidy. The cost of the test without subsidy is
S$22.26.
Non-reactive HIV screening test results were conveyed to the
patients by the HIV counselors. While offering bedside educa-
tional information patients were advised that should their results
not be available at the time of discharge, they could call a
designated number to collect the result at a later date; this
information is also provided in the educational brochure given to
patients at the time of admission. Reactive HIV screening test
results were conveyed to the primary physician who was directed
to follow up on the confirmatory HIV Western blot assay result
and was deemed responsible for informing patients. On confir-
mation with HIV Western blot assay, patients were referred by the
primary care physician to an Infectious Disease physician in
TTSH for specialty HIV care at the Communicable Disease
Centre (CDC).
From the 24
th to 30
th of November 2010, all patients who opted
out of the HIV screening test were asked about their reasons for
opting out. The reasons were collected and recorded with their
verbal consent without other identifiers recorded.
We evaluated the total number of patients who were admitted
in TTSH during the 2-year review period and determined the
number of patients who agreed to be HIV tested, number of
patients with reactive screening tests, number of confirmed HIV
infections among those tested and the rate of linkages to HIV care
and treatment. Data was obtained through the Management
Information Department of the Office of Clinical Governance of
TTSH. We obtained demographic data on sex, age, ethnicity, and
International Classification of Disease (ICD) diagnosis on patients
who met eligibility criteria. Data from patients who opted out were
compared to those who opted in for HIV screening test. SPSS for
Windows Version 18.0 was used for all statistical analyses. We
compared proportions using Pearson Chi-square, means using
ANOVA tests, and medians using Kruskal-Wallis test. Logistic
regression was used to test the associations in a multivariate model
using the Wald test.
Medical records of patients diagnosed with HIV infection were
reviewed. Data including stage of HIV infection, presence of AIDS
defining illness, CD4 count on presentation, as well as links to
care, antiretroviral therapy status and outcome were obtained.
This study was reviewed and approved by the Singapore
National Health Care Group (NHG) Domain Specific Ethics
Review Board Committee.
Results
During the 24-month review period, TTSH received a total of
93,211 admissions; 51,668 patients were excluded from the HIV
screening program based on eligibility criteria. Among those who
were eligible, 79% (n=32,675) opted out of HIV screening. There
were a total of 8,868 patients who did not opt out (21% acceptance
or uptake rate with 99% of these patients actually receiving an
HIV screening test (Table 1).
The profile of the patients included in the screening program is
the same as the entire admitted population in TTSH from the
same period (2009–2010) in terms of gender, 55% male and 45%
female. The age distribution of the patients included in the HIV
screening program for the 20–59 year old group is 48% (vs 44%
for admitted population in TTSH) and for the 60 and above year
old group is 52% (vs 56% for admitted population in TTSH) (Data
from Annual report 2009 and 2010, Hospital Statistics, Quality
Management Information System, Tan Tock Seng Hospital).
The demographic characteristics of patients who opted in and
opted out of the HIV screening program are shown in Table 2.
The majority of eligible patients who were tested (63%) were men.
The mean age of tested patients was 52 years (range: 21–95 years).
Chinese ethnicity account for 61% of those tested, while 17% are
Malay and 17% are Indians. In univariate analysis, the opt out
Table 1. Data on Total Admissions and Opt Out Voluntary HIV Testing (January 1, 2009 to December 31, 2010).
Total Admissions 93,211
Total number of patients included in HIV screening program 41,543 (45%)
Total eligible patients who opted out of HIV screening 32,675 (35%) [32,675 / 93,211 total admissions] (78.6%) [32,675/41,543 eligible
patients]
Total eligible patients who opted in to HIV screening 8,868 (9.5%) [8,868 / 93,211 total admissions] (21%) [8,868/41,543 eligible patients]
doi:10.1371/journal.pone.0034663.t001
Table 2. Demographic characteristics of patients included in
the HIV screening program.
Variables
Opt In
n=8,868 (%)
Opt Out
n=32,625 (%)
Odds Ratio
(95% CI) p value
Gender
Male 5,576 (24) 17,332 (76) 1
Female 3,392 (17) 15,343 (82) 1.5 (1.4–1.6) ,0.01
Age
20–59 5,684 (29) 14,200 (71) 1
60–109 3,184 (15) 18,475 (85) 2.3 (2.2–2.4) ,0.001
Mean (SD) 52.7 (16.6) 60.7 (17.2) - ,0.001
Median (IQR) 53 (41–65) 62 (49–74) - ,0,001
Ethnicity
Chinese 5,418 (19) 23,881 (82) 1.7 (1.6–1.8) ,0.001
Indian 1,336 (29) 3,347 (71) 1
Malay 1,514 (28) 3,824 (72) 1.0 (0.9–1.1) .0.20
Others 600 (27) 1,623 (73) 1.1 (1.0–1.2) 0.18
doi:10.1371/journal.pone.0034663.t002
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1.4–1.6), among those aged .60 years (OR: 2.3, 95% CI 2.2–2.4)
and among Chinese ethnicity (OR: 1.7, 95% CI 1.6–1.8). The
association with age persists in a multivariate regression analysis
after adjustment on ethnicity and gender.
Sixty-six patients had a reactive HIV antibody test, of which 15
were confirmed to have HIV infection by a positive Western blot
assay; 47 had a negative Western blot. There were 4 indeterminate
Western blot results 21 false positive (undetectable HIV RNA
assay), 2 did not have further follow up after being advised to
undergo repeat HIV testing, and 1 had acute HIV seroconversion
illness. The false positive rate of the HIV screening test is
0.56%.
All 16 confirmed HIV patients represented new HIV diagnoses.
Table 3 summarizes the demographic and clinical characteristics
of these patients. All patients were men and 75% were of Chinese
ethnicity. The median age was 51 years (range 23–74 years) with 3
patients .70 years old. The median CD4 count was 150 cells/
mm
3 (range: 20–543 cells/mm
3) with 69% having a CD4#200
cells/mm
3. Five patients presented with an AIDS-defining
condition. All 16 patients were referred to an infectious disease
(ID) specialist. The median duration to being seen by an ID
specialist from the date of referral was 8 days (range: 0 to 20 days).
At time of review of medical records, 11 patients remain in active
follow up; 9 are receiving antiretroviral (ARV) therapy. The 2
patients not receiving treatment do not require ARV based on
current HIV treatment guidelines. Among the 5 patients who are
not in active follow up, 1 has died, 1 is receiving palliative care for
a non AIDS defining malignancy and 3 have not followed up in
clinic as scheduled or have defaulted. The reasons for defaulting
follow up included not being ready to accept the HIV diagnosis
and refusal to take antiretroviral therapy.
Table 4 shows the commonly cited reasons for refusing an HIV
test. The most common reason patients reported for opting out
was that patients did not think that they had risk factors for
acquiring HIV infection, followed by fear of venipuncture.
Table 3. Characteristics of HIV Patients diagnosed through Screening Program.
n
Number of HIV patients 16
Sex:
- Male 16
Median Age (range) 51 y (23–75)
Ethnicity:
- Chinese 12
- Malay 3
- Indian 1
Risk Factors:
- MSM 3
- Bisexual 1
- Heterosexual 11
- Unknown 1
Previous HIV Testing:
- No previous HIV Test 12
- Previous HIV Test 2
- Unknown HIV testing history 2
Presence of AIDS-Defining Illness on diagnosis 5
Median CD4 count (range) 150 (,20 to 543)
Other medical comorbidities‘ 18
Median number of days from date of HIV test to referral to ID (min-max) 8 days (1 to 300)
Median number of days from date of referral to being seen by ID Specialist 8 days (0 to 20)
Outcome:
- In active follow up: 11
Receiving antiretroviral therapy 9
Not receiving antiretroviral therapy 2‘‘
- Default 3
- Palliative Care 1
- Death 1
Number of patients in active follow up receiving antiretroviral therapy 9
‘Medical comorbidities include: hypertension, diabetes, hyperlipidemia, coronary artery disease, depression, gout, benign prostatic hyperplasia, chronic hepatitis B,
alcoholic liver disease.
‘‘Not indicated to receive antiretroviral therapy based on current WHO HIV treatment guidelines.
doi:10.1371/journal.pone.0034663.t003
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While the prevalence of HIV in Singapore remains low
compared to other countries in Southeast Asia and globally, the
majority of newly diagnosed HIV individuals are in the advanced
stage of the infection. Patients are most often identified as HIV
infected when they present with clinical symptoms or with an
AIDS-defining condition [1]. The delay from HIV infection to
testing and treatment represents a lost opportunity for early HIV
treatment, as well as, prevention of HIV transmission risk to
uninfected partners.
Our program showed that 55% of all patients admitted to our
hospital are excluded from the opt out HIV testing program based
on exclusion criteria. And among those who were eligible, only
21% agreed to the HIV test. All patients diagnosed with HIV were
linked to care.
Low Proportion of HIV among those tested:
The proportion of patients who were positive among those who
tested was low at 0.18%. Compared with other testing strategies
(Table 5), the lower prevalence can be due to the reason that those
who agree to testing have lower pre test probability of having HIV
infection. In comparison, in 2007, the anonymous testing site of
Action for AIDS in Singapore reported an overall prevalence rate
of 1.8%, with the majority (5.7%) accounted for by men having
sex with men (MSM) while heterosexual males accounted for 0.8%
[7].
The high false positive rate we noted in our study (0.56%) could
be accounted for by the very low prevalence rate of HIV among
those screened.
However, assuming the prevalence of HIV is similar among
various inpatients in major hospitals and that HIV infected
patients present as inpatients at the same frequency, we estimate
from our findings that this testing effort could identify around 40–
50 HIV infected patients per year. Therefore the absolute yield
from this testing strategy is potentially significant. Studies of
routine HIV testing done in the US have been conducted with
calculation of the costs of identifying and treating HIV cases
measured against the cost of averting potential new infections.
Results have shown the cost effectiveness of this strategy [8–10].
High Proportion of patients who are excluded from Opt
Out HIV testing based on eligibility criteria
In our study, the voluntary opt out HIV testing strategy in the
inpatient setting misses 55% of the patients admitted based on
baseline exclusion criteria. The proportion of patients who had an
HIV screening test among all patients admitted in the hospital
during the period was only 9.5% (Table 1). Screening in the
inpatient setting will miss patients who may be too ill to consent to
HIV testing. A complementary testing strategy would be to
routinely offer HIV testing to patients in the outpatient primary
care setting, and package HIV testing with other standard tests
such as cholesterol and blood glucose screening.
Low Acceptance Rate of HIV testing
Our overall opt in rate was low at 21%. The low acceptance
rate of HIV testing in Singapore remains a major obstacle in
assessing the true yield of this testing strategy. Limited literature on
routine inpatient HIV testing varies from 24% acceptance rate in a
Veterans Affairs Hospital to 64.9% in an urban hospital with an
emergency department using a rapid HIV testing program in the
United States [5,6]. Table 5 shows the higher acceptance rate
during antenatal HIV screening. This is not surprising given that
mothers do not want to inadvertently pass HIV to their infants.
The most common reason for declining HIV testing was the
patient’s perception that they were at low risk or had no risk of
contracting HIV. Studies from other countries show that there is a
significant discrepancy between respondents acknowledging risk
behavior and perceiving risk, and that individuals tend to
underestimate their potential risk for HIV infection [11].
Our evaluation shows that patients with characteristics
including Chinese ethnicity, age $60 years are more likely to
opt out of HIV testing. This is a concern for a number of reasons.
First, according to MOH data, the proportion of newly diagnosed
older HIV patients for the past 10 years is between 27–30% [1].
Second, data also shows that compared to younger newly
diagnosed HIV individuals, the older HIV individual tend to
have a lower CD4 count (Data, HIV Programme, Communicable
Disease Centre, 2008–2010). The lower CD4 count among older
HIV individuals relates either to the age or the late stage at which
HIV is diagnosed. Older individuals as well as their medical
Table 5. Comparison of various HIV screening tests conducted in Singapore.
3 HIV Screening Strategies
Number of Individuals
Tested Group Tested HIV Testing uptake, %
Proportion of HIV among
those tested, %
A 6,903 High risk - 1.8%
B 8,868 Low to High risk 21% 0.18%
C 15,945 Low risk 99.42% 0.05%
A : January 2007 to December 2007: Action For AIDS (AFA)- Anonymous Testing Site
6 : [MSM-5.7%, Heterosexual male-0.8%, Heterosexual female- 0.4%].
B: January 2009 to December 2010.
TTSH- Routine Voluntary Opt Out Inpatient HIV testing Program (This study).
C: January 2010 to December 2010 to Antenatal Screening From acute public hospitals and polyclinics (Data from Communicable Disease Division, MOH, Singapore
2010).
doi:10.1371/journal.pone.0034663.t005
Table 4. Reasons cited for opting out of HIV Screening Test.
Reason N %
Financial Issue 24 9.3
Deemed no risk factors (ie, old age, no
sexual contact)
144 55.8
Fear of blood test/needles 58 22.4
Others* 32 12.4
Total 258 100.0
*Other reasons cited include: fear of results, family objected, wants to
resolve current medical illness first, deemed low risk.
doi:10.1371/journal.pone.0034663.t004
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Prevention campaigns in Singapore have also generally targeted
younger people and among the MSM community. Likewise, HIV
testing campaigns have not been geared toward older adults.
Without proper perception of individual risks, it is possible that opt
out HIV testing will not improve uptake of HIV screening as most
of the patients will deem themselves without risk and thus do not
see the need of having an HIV test. Increased awareness among
doctors is likewise needed so that patients are assessed routinely for
risk factors for HIV regardless of age and sexual orientation and
are offered HIV testing regularly in the course of medical care.
Venipuncture has been implicated as a barrier to patients
receiving an HIV test in our program, suggesting that the
availability of saliva-based rapid testing maybe a key to improving
patient acceptance. However, the higher cost of the rapid test may
present a barrier not present for the government-subsidized
serum-based HIV test. The current cost of the oral based test in
Singapore is around S$28 compared to the subsidized price of the
blood based HIV test (S$6–10). A possible approach would be to
perform the HIV test at the same time as another blood test during
the hospitalization, to avoid additional venipuncture by collecting
a separate dedicated tube for the HIV test.
Finally, fear of receiving a positive HIV test result was
mentioned as a reason for opting out. Patients may fear dying
from HIV, the financial burden of antiretroviral treatment, and
the loss of job, family, and friends. It is evident that the major
challenges of HIV in Singapore remains to be HIV related stigma
and discrimination [12]. A National Survey on public attitudes
towards people living with HIV/AIDS (PLWHA) conducted in
2007 show that 54.1% of respondents would care for a close
relative who became ill due to HIV/AIDS in their own home,
22.4% are willing to share a meal with a person living with HIV
and only 18.2% would buy food from a shopkeeper living with
HIV [13]. Acknowledging this major obstacle, the Ministry of
Health (MOH) together with community partners have increased
their efforts to address stigma and discrimination towards people
living with HIV.
Limitations
We were only able to survey the reasons for opting out of HIV
testing only from a small proportion of patients. There might be
possible differences in this group compared to those who were not
surveyed. A more extensive survey may be warranted in the future
to understand the reasons for opting out. The other limitation of
our study is the generalizability of our results to other Singapore
hospitals and the general population.
While we have shown that it is possible to conduct routine
voluntary opt out inpatient HIV testing in our hospital, and that
those that opt in and receive a new HIV diagnosis are successfully
linked to care, more efforts are needed to address reasons for
opting out of HIV testing. This could include education campaigns
that address individual risk perception for HIV in conjunction
with anti HIV stigma and anti-discrimination campaigns in the
general population.
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